In a follow-up study this finding was validated in a larger cohort of 109 STS patients (HR = 1.41; 95% CI, 1.03–1.94; p = 0.03), suggesting that high NG2 expression might be useful in predicting metastasis development in STS patients (62). Here, CSPG4 is linked to telomere syndrome.